• New Illumina CTO, Q2 Updates

    Bio-IT World | Illumina today announced that Alex Aravanis, CTO, has departed Illumina to pursue an opportunity outside of the company effective immediately. In his place, Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO).

    Aug 9, 2023

  • Using ML to Diagnose Chronic Kidney Disease in a Bias-Free, Privacy-Protecting, Physician-Friendly Manner

    Bio-IT World | Carenostics is a healthcare AI startup founded with the mission of addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML on existing healthcare data.

    Aug 9, 2023

  • Generate Biomedicines’ R&D Data Platform to Support ML-Driven Drug Discovery

    Bio-IT World | “Generate Biomedicines’ goal of leveraging machine-learning powered generative biology to discover and develop new drugs faster and cheaper is supported by an integrated and cohesive R&D data platform… FAIR to its core, this integrated data platform leverages industry best practices and lessons-learned from a talented team of informatics engineers to form the critical foundation of a unique company with equal parts ‘bio’ and ‘tech’.”

    Aug 8, 2023

  • An AI Tool for Lung Cancer Diagnosis in Indian Populations, Settings

    Bio-IT World | The prognosis of lung carcinoma has changed since the discovery of molecular targets and their specific drugs. Somatic EGFR mutations have been reported in lung carcinoma, and these mutant proteins act as substrates for targeted therapies.

    Aug 3, 2023

  • Discovery To Creation: Highlights from the 2023 Single-Cell and AI in Medicine Symposium

    Bio-IT World | The field of drug discovery is shifting its approach from viewing complex biology as something to be overcome using reductionist principles to something to embrace in a more holistic approach to cell biology.

    Aug 2, 2023